- Home
- EVGN vs MTEM Comparison
EVGN vs MTEM Comparison
Compare EVGN & MTEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGN
- MTEM
- Stock Information
- Founded
- EVGN 1999
- MTEM 2001
- Country
- EVGN Israel
- MTEM United States
- Employees
- EVGN N/A
- MTEM N/A
- Industry
- EVGN Agricultural Chemicals
- MTEM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVGN Industrials
- MTEM Health Care
- Exchange
- EVGN Nasdaq
- MTEM Nasdaq
- Market Cap
- EVGN 9.7M
- MTEM 9.7M
- IPO Year
- EVGN N/A
- MTEM N/A
- Fundamental
- Price
- EVGN $1.65
- MTEM $0.39
- Analyst Decision
- EVGN Strong Buy
- MTEM
- Analyst Count
- EVGN 1
- MTEM 0
- Target Price
- EVGN $12.00
- MTEM N/A
- AVG Volume (30 Days)
- EVGN 800.3K
- MTEM 17.8M
- Earning Date
- EVGN 11-21-2024
- MTEM 11-26-2024
- Dividend Yield
- EVGN N/A
- MTEM N/A
- EPS Growth
- EVGN N/A
- MTEM N/A
- EPS
- EVGN N/A
- MTEM N/A
- Revenue
- EVGN $9,449,000.00
- MTEM $25,470,000.00
- Revenue This Year
- EVGN $173.12
- MTEM N/A
- Revenue Next Year
- EVGN $33.10
- MTEM N/A
- P/E Ratio
- EVGN N/A
- MTEM N/A
- Revenue Growth
- EVGN 290.29
- MTEM N/A
- 52 Week Low
- EVGN $1.56
- MTEM $0.30
- 52 Week High
- EVGN $10.40
- MTEM $5.37
- Technical
- Relative Strength Index (RSI)
- EVGN 30.75
- MTEM 39.30
- Support Level
- EVGN $1.66
- MTEM $0.32
- Resistance Level
- EVGN $1.78
- MTEM $0.62
- Average True Range (ATR)
- EVGN 0.17
- MTEM 0.11
- MACD
- EVGN -0.01
- MTEM 0.03
- Stochastic Oscillator
- EVGN 10.98
- MTEM 8.40
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.
About MTEM Molecular Templates Inc.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.